Provided by Tiger Trade Technology Pte. Ltd.

ADMA Biologics

9.55
-0.2900-2.95%
Post-market: 9.46-0.0900-0.94%17:00 EDT
Volume:1.96M
Turnover:18.90M
Market Cap:2.14B
PE:13.64
High:9.91
Open:9.80
Low:9.54
Close:9.84
52wk High:20.46
52wk Low:7.21
Shares:223.98M
Float Shares:210.51M
Volume Ratio:1.06
T/O Rate:0.93%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7004
EPS(LYR):0.6000
ROE:41.90%
ROA:21.78%
PB:5.24
PE(LYR):15.92

Loading ...

ADMA Biologics Leans on ASCENIV in Earnings Call

TIPRANKS
·
Aug 21

ADMA Biologics (ADMA) After Strong Q2 Results And Reaffirmed Guidance Is It A Bargain

Simply Wall St.
·
Aug 19

Why ADMA Biologics (ADMA) Is Up 5.6% After Reaffirming 2026 Revenue Guidance And EPS Momentum

Simply Wall St.
·
Aug 13

ADMA Biologics (ADMA) Is Up 6.3% After Faster Net Income Growth Than Sales In Q2 2026

Simply Wall St.
·
Aug 06

ADMA Biologics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

ADMA Biologics Q2 2026 Earnings: ASCENIV Mix Drives Margin Expansion

TradingKey
·
Aug 06

ADMA Biologics Q2 GAAP Net Income Rises 11% to $37.8 Million; Revenue Increases 2% to $124.4 Million

Reuters
·
Aug 06

ADMA Biologics Q2 Adj. EPS $0.16 Misses $0.17 Estimate, Sales $124.395M Miss $131.658M Estimate

Benzinga Earnings
·
Aug 06

ADMA Biologics Q2 Net Income USD 37.822 Million

Reuters
·
Aug 06

ADMA Biologics Inc Expected to Post Earnings of 17 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Fraud And Revenue-Recognition Lawsuits Could Be A Game Changer For ADMA Biologics (ADMA)

Simply Wall St.
·
Jul 30

ADMA Biologics to Report Second Quarter 2026 Financial Results on August 5, 2026

GlobeNewswire
·
Jul 29

3 U.S. Drug Manufacturing Stocks Investors Are Watching As Tariffs Rise

Simply Wall St.
·
Jul 22

ADMA Biologics is Maintained at Outperform by Mizuho

Dow Jones
·
Jul 16

ADMA Biologics (ADMA) Puts Growth Narrative To The Test As Fair Value Stays In Focus

Simply Wall St.
·
Jul 15

ADMA Biologics Faces Securities Fraud Class Action Over Channel Stuffing Allegations

Deep News
·
Jul 07

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.
·
Jul 06

How Index Inclusion and Legal Scrutiny Will Impact ADMA Biologics (ADMA) Investors

Simply Wall St.
·
Jul 04

ADMA Biologics (ADMA) Could Be 51% Undervalued On Securities Fraud Lawsuits

Simply Wall St.
·
Jun 26

Is Securities Fraud Litigation Over Reported ASCENIV Sales Altering The Investment Case For ADMA Biologics (ADMA)?

Simply Wall St.
·
Jun 24